Senology.org - NewsletterInternational Senologic and Oncologic  Scientific Community (ISOSC) "Connecting specialists world...
Editorial"Use of medications to reduce breast cancer risk", Heidi D. Nelson, Oregon Health & Science University,Veterans A...
Zhang X et al.: "Associations of self-reported sleep duration and snoring with colorectal cancer risk inmen and women", Sl...
     www.senology.orgSenology.it NewsletterPage 4 of 4Senology Newsletter04/06/2013file://C:Documents and SettingsutenteDe...
Upcoming SlideShare
Loading in …5
×

Senology Newsletter - June 4, 2013

331 views

Published on

Latest Advances in Clinical Senology and Oncology

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
331
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Senology Newsletter - June 4, 2013

  1. 1. Senology.org - NewsletterInternational Senologic and Oncologic  Scientific Community (ISOSC) "Connecting specialists worldwide"June 4, 2013Editor-in-Chief: Gian Paolo Andreoletti, MDSenology apps for iPad, iPhone, and Android tablets now available, to provide anytime, anywhere access to Senology contentsJoin us on LinkedIn, Twitter, Facebook, YouTube, ResearchGate, SlideShare, Flickr, and share comments.Read Senology Newspaper dailySenology collaborates withLiterature SelectionJiang W et al.: "Coffee and caffeine intake and breast cancer risk: An updated dose-response meta-analysis of 37 published studies", Gynecol Oncol. 2013 Jun;129(3):620-9Poole EM et al.: "Postdiagnosis supplement use and breast cancer prognosis in the After BreastCancer Pooling Project", Breast Cancer Res Treat. 2013 May 10. [Epub ahead of print]Cooke R et al.: "Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrualand reproductive factors", Br J Cancer. 2013 May 7[Epub ahead of print]Schaverien MV et al.: "Effect of neoadjuvant chemotherapy on outcomes of immediate freeautologous breast reconstruction", Eur J Surg Oncol. 2013 May;39(5):430-6Wong AW et al.: "Prophylactic use of levonorgestrel-releasing intrauterine system in women withbreast cancer treated with tamoxifen: a randomized controlled trial", Obstet Gynecol. 2013 May;121(5):943-50Tran BH et al.: "Risk factors associated with venous thromboembolism in 49,028 mastectomypatients", Breast. 2013 May 18 [Epub ahead of print]van Hoesel AQ et al.: "Assessment of DNA methylation status in early stages of breast cancerdevelopment", Br J Cancer. 2013 May 7 [Epub ahead of print]Page 1 of 4Senology Newsletter04/06/2013file://C:Documents and SettingsutenteDesktopPAOLONewsl_June_2013.htm
  2. 2. Editorial"Use of medications to reduce breast cancer risk", Heidi D. Nelson, Oregon Health & Science University,Veterans Affairs Medical Center, Portland, OR, USA"Our review on use of medications to reduce risk for primary breast cancer indicated that tamoxifen andraloxifene reduced the incidence of invasive breast cancer in women without cancer, but also increased riskfor blood clots. Tamoxifen was more effective than raloxifene in reducing breast cancer, but also increasedthe incidence of endometrial cancer and cataracts. Both reduced fractures. Adverse effects were morecommon in older compared to younger women. Wide-spread use is limited by the adverse effects ofmedications and inaccurate methods to identify candidates. Medications reduce invasive breast cancer by 7to 9 cases per 1000 women, assuming 5-years of use. There are 5 per 1000 fewer cases among womenusing tamoxifen than raloxifene. Estrogen receptor positive breast cancers were reduced, but not estrogenreceptor negative"(Commentary on: Nelson H et al.: "Use of medications to reduce risk for primary breast cancer: asystematic review for the u.s. Preventive services task force", Ann Intern Med. 2013 Apr 16;158(8):604-14)Questions and AnswersBreast Cancer Workshop Summary - with Katherine Crew, New York-Presbyterian/Columbia UniversityMedical Center, New York, NY, USADiscussion"Guidelines for sentinel lymph node biopsy in contralateral prophylactic mastectomy need to beestablished to avoid overtreatment" - Share your opinion on LinkedInFragments of History1981 - Umberto Veronesi, National Cancer Institute, Milan, Italy - "In conclusion, the data from our trial showthat patients with early breast cancer who are treated with quadrantectomy and axillary dissection plusradiotherapy have the same survival rate and the same incidence of local and distant recurrences as patientswho are treated with the Halsted mastectomy. On the basis of this study, radical mastectomy appears toinvolve unnecessary mutilation in patients with carcinoma of the breast measuring less than 2 cm and withoutpalpable axillary nodes". (Veronesi U et al.: "Comparing radical mastectomy with quadrantectomy,axillary dissection, and radiotherapy in patients with small cancers of the breast", N Engl JMed.1981Jul 2;305(1):6-11)Calendar of Events15th Milan Breast Cancer Conference, June 20-21, 2013, Milan, Italy3rd World Congress on Cancer Science & Therapy, October 21-23, 2013, San Francisco, CA, USA - inpartnership with Senology9th Meet the Professor. Advanced International Breast Cancer Conference (AIBCC), November 11-13,Padova, Italy - under the Patronage of SenologyUpdate in Breast Imaging, 22-23 November, Ostend, BelgiumLiterature SelectionMathews JD et al.: "Cancer risk in 680 000 people exposed to computed tomography scans inchildhood or adolescence: data linkage study of 11 million Australians", BMJ. 2013 May 21;346:f2360Mols F et al.: "Depressive symptoms are a risk factor for all-cause mortality: results from aprospective population-based study among 3,080 cancer survivors from the PROFILES registry", JCancer Surviv. 2013 May 16. [Epub ahead of print]Duo J et al.: "Comparison of FDG PET/CT and Gadolinium-Enhanced MRI for the Detection of BoneMetastases in Patients With Cancer: A Meta-analysis", Clin Nucl Med. 2013 May;38(5):343-8Langevin SM et al.: "Gastric Reflux Is an Independent Risk Factor for Laryngopharyngeal Carcinoma",Cancer Epidemiol Biomarkers Prev. 2013 May 23. [Epub ahead of print]Page 2 of 4Senology Newsletter04/06/2013file://C:Documents and SettingsutenteDesktopPAOLONewsl_June_2013.htm
  3. 3. Zhang X et al.: "Associations of self-reported sleep duration and snoring with colorectal cancer risk inmen and women", Sleep. 2013 May 1;36(5):681-8Sigurdardottir LG et al.: "Sleep disruption among older men and risk of prostate cancer", CancerEpidemiol Biomarkers Prev. 2013 May;22(5):872-9Daskivich TJ et al.: "Effect of Age, Tumor Risk, and Comorbidity on Competing Risks for Survival in aU.S. Population-Based Cohort of Men With Prostate Cancer", Ann Intern Med. 2013 May 21;158(10):709-717The National Lung Screening Trial Research Team : "Results of Initial Low-Dose ComputedTomographic Screening for Lung Cancer", N Engl J Med. 2013 May 23;368(21):1980-1991Pasquier E et al.: "β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma", Br J Cancer. 2013 May 21 [Epub ahead of print]Questions and AnswersLiver Cancer Workshop Summary - with Richard Finn, UCLA Jonsson Comprehensive Cancer Center, LosAngeles, CA, USAKidney Cancer Workshop Summary - with William Huang, NYU Langone Medical Center, New York, NY,USAMelanoma Workshop Summary - with Patrick Hwu, The University of Texas MD Anderson Cancer Center,Houston, TX, USACervical Cancer Workshop Summary - with Stewart Massad, Washington University, St. Louis, MO, USALung Cancer Workshop Summary - with Glen J. Weiss, Cancer Treatment Centers of America, Goodyear,AZ, USALiterature SelectionDobson SR et al.: "Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses inyoung women: a randomized clinical trial", JAMA. 2013 May 1;309(17):1793-802Yang HP et al.: "Ovarian Cancer Incidence Trends in Relation to Changing Patterns of MenopausalHormone Therapy Use in the United States", J Clin Oncol. 2013 May 6. [Epub ahead of print]Stay informed....Recent Advances in Clinical MedicineJanssen HL et al.: "Treatment of HCV infection by targeting microRNA ", N Engl J Med. 2013 May2;368(18):1685-94Jacobson IM et al.: "“Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatmentoptions”, N Engl J Med. 2013 May 16;368(20):1867-77Subscribe Unsubscribe Contact Back IssuesPage 3 of 4Senology Newsletter04/06/2013file://C:Documents and SettingsutenteDesktopPAOLONewsl_June_2013.htm
  4. 4.      www.senology.orgSenology.it NewsletterPage 4 of 4Senology Newsletter04/06/2013file://C:Documents and SettingsutenteDesktopPAOLONewsl_June_2013.htm

×